Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to ascertain whether treatment with the drug eplerenone, taken
early after a heart attack, prevents or reduces some of the adverse changes that may
otherwise naturally occur within the heart muscle, that lead ultimately to weakening of the
heart muscle and premature death.